Identification and quantification of AKT isoforms and phosphoforms in breast cancer using a novel nanofluidic immunoassay

Molecular and Cellular Proteomics

Volumn 12, Issue 11, 2013, Pages 3210-3220

  Iacovides, Demetris C ^b   Johnson, Aimee B ^a   Wang, Nick ^c   Boddapati, Shanta ^c   Korkola, Jim ^c   Gray, Joe W ^c  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CYPRUS   (Cyprus)

^c Oregon Health and Science University Department of Biomedical Engineering   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN AKT 1; PROTEIN AKT 3; PROTEIN KINASE B; PROTEIN KINASE B BETA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME PHOSPHORYLATION; IMMUNOASSAY; ISOELECTRIC POINT; MULTIPLE CANCER; NANOCAPILLARY ELECTROPHORESIS IMMUNOASSAY; NANOFLUIDICS; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

BREAST NEOPLASMS; CELL LINE, TUMOR; ELECTROPHORESIS, CAPILLARY; FEMALE; HUMANS; IMMUNOASSAY; ISOENZYMES; METABOLIC NETWORKS AND PATHWAYS; MICROFLUIDIC ANALYTICAL TECHNIQUES; NANOTECHNOLOGY; OXADIAZOLES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-AKT; QUINAZOLINES;

EID: 84887034220     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.023119     Document Type: Article

References (32)

1. Engelman, J. A. (2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat. Rev. Cancer 9(8), 550-562.
2. Brugge, J., Hung, M. C., and Mills, G. B. (2007) A new mutational AKTivation in the PI3K pathway. Cancer Cell 12(2), 104-107. (Pubitemid 47199129)
3. Franke, T. F. (2008) PI3K/Akt: getting it right matters. Oncogene 27(50), 6473-6488.
4. Coffer, P. J., Jin, J., and Woodgett, J. R. (1998) Protein kinase B (c-akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 1(335 Pt 1), 1-13. (Pubitemid 28477043)
5. Stephens, L., Anderson, K., Stokoe, D., Erdjument-Bromage, H., Painter, G. F., Holmes, A. B., Gaffney, P. R., Reese, C. B., McCormick, F., Tempst, P., Coadwell, J., and Hawkins, P. T. (1998) Protein kinase B kinases that mediate phosphatidylinositol 3, 4, 5-trisphosphate-dependent activation of protein kinase B. Science 279(5351), 710-714. (Pubitemid 28144551)
6. Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R., Reese, C. B., and Cohen, P. (1997) Characterization of a 3-phosphoinositide- dependent protein kinase which phosphorylates and activates protein kinase balpha. Curr. Biol. 7(4), 261-269. (Pubitemid 27176852)
7. Stokoe, D., Stephens, L. R., Copeland, T., Gaffney, P. R., Reese, C. B., Painter, G. F., Holmes, A. B., McCormick, F., and Hawkins, P. T. (1997) Dual role of phosphatidylinositol-3, 4, 5-trisphosphate in the activation of protein kinase B. Science 277(5325), 567-570. (Pubitemid 27369005)
8. Sarbassov, D. D., Guertin, D. A., Ali, S. M., and Sabatini, D. M. (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307(5712), 1098-1101. (Pubitemid 40262113)
9. Lindsley, C. W., Barnett, S. F., Layton, M. E., and Bilodeau, M. T. (2008) The PI3K/Akt pathway: recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors. Curr. Cancer Drug Targets 8(1), 7-18. (Pubitemid 351237905)
10. Sasaki, T., Nakashiro, K., Tanaka, H., Azuma, K., Goda, H., Hara, S., Onodera, J., Fujimoto, I., Tanji, N., Yokoyama, M., and Hamakawa, H. (2010) Knockdown of Akt isoforms by RNA silencing suppresses the growth of human prostate cancer cells in vitro and in vivo. Biochem. Biophys. Res. Commun. 399(1), 79-83.
11. Koseoglu, S., Lu, Z., Kumar, C., Kirschmeier, P., and Zou, J. (2007) AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines. Cancer Biol. Ther. 6(5), 755-762. (Pubitemid 47328358)
12. Yang, W., Ju, J. H., Lee, K. M., and Shin, I. (2011) Akt isoform-specific inhibition of MDA-MB-231 cell proliferation. Cell Signal. 23(1), 19-26.
13. Li, X., Lu, Y., Jin, W., Liang, K., Mills, G. B., and Fan, Z. (2006) Autophosphorylation of Akt at threonine 72 and serine 246. A potential mechanism of regulation of Akt kinase activity. J. Biol. Chem. 281(19), 13837-13843. (Pubitemid 43855299)
14. Alessi, D. R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P., and Hemmings, B. A. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15(23), 6541-6551. (Pubitemid 26413787)
15. Chen, R., Kim, O., Yang, J., Sato, K., Eisenmann, K. M., McCarthy, J., Chen, H., and Qiu, Y. (2001) Regulation of Akt/PKB activation by tyrosine phosphorylation. J. Biol. Chem. 276(34), 31858-31862.
16. O'Neill, R. A., Bhamidipati, A., Bi, X., Deb-Basu, D., Cahill, L., Ferrante, J., Gentalen, E., Glazer, M., Gossett, J., Hacker, K., Kirby, C., Knittle, J., Loder, R., Mastroieni, C., Maclaren, M., Mills, T., Nguyen, U., Parker, N., Rice, A., Roach, D., Suich, D., Voehringer, D., Voss, K., Yang, J., Yang, T., and Vander Horn, P. B. (2006) Isoelectric focusing technology quantifies protein signaling in 25 cells. Proc. Natl. Acad. Sci. U.S.A. 103(44), 16153-16158. (Pubitemid 44717502)
17. Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J. P., Tong, F., Speed, T., Spellman, P. T., DeVries, S., Lapuk, A., Wang, N. J., Kuo, W. L., Stilwell, J. L., Pinkel, D., Albertson, D. G., Waldman, F. M., McCormick, F., Dickson, R. B., Johnson, M. D., Lippman, M., Ethier, S., Gazdar, A., and Gray, J. W. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10(6), 515-527. (Pubitemid 44854747)
18. Blume-Jensen, P., and Hunter, T. (2001) Oncogenic kinase signalling. Nature 411(6835), 355-365. (Pubitemid 32467045)
19. Hers, I., Vincent, E. E., and Tavare, J. M. (2011) Akt signalling in health and disease. Cell Signal. 23(10), 1515-1527.
20. Nicholson, K. M., and Anderson, N. G. (2002) The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal. 14(5), 381-395. (Pubitemid 34214843)
21. Altomare, D. A., and Testa, J. R. (2005) Perturbations of the AKT signaling pathway in human cancer. Oncogene 24(50), 7455-7464. (Pubitemid 41637985)
22. Cheng, J. Q., Lindsley, C. W., Cheng, G. Z., Yang, H., and Nicosia, S. V. (2005) The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene 24(50), 7482-7492. (Pubitemid 41637988)
23. Yuan, T. L., and Cantley, L. C. (2008) PI3K pathway alterations in cancer: variations on a theme. Oncogene 27(41), 5497-5510.
24. Rusch, V., Klimstra, D., Venkatraman, E., Pisters, P. W., Langenfeld, J., and Dmitrovsky, E. (1997) Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. Clin. Cancer Res. 3(4), 515-522. (Pubitemid 27211827)
25. Giatromanolaki, A., Koukourakis, M. I., O'Byrne, K., Kaklamanis, L., Dicoglou, C., Trichia, E., Whitehouse, R., Harris, A. L., and Gatter, K. C. (1996) Non-small cell lung cancer: C-erbB-2 overexpression correlates with low angiogenesis and poor prognosis. Anticancer Res. 16(6B), 3819-3825. (Pubitemid 27085055)
26. Downward, J. (2003) Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3(1), 11-22. (Pubitemid 37328883)
27. Shayesteh, L., Lu, Y., Kuo, W. L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, B., Mills, G. B., and Gray, J. W. (1999) PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet. 21(1), 99-102. (Pubitemid 29036292)
28. Mende, I., Malstrom, S., Tsichlis, P. N., Vogt, P. K., and Aoki, M. (2001) Oncogenic transformation induced by membrane-targeted Akt2 and Akt3. Oncogene 20(32), 4419-4423. (Pubitemid 32726886)
29. Cheng, J. Q., Ruggeri, B., Klein, W. M., Sonoda, G., Altomare, D. A., Watson, D. K., and Testa, J. R. (1996) Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc. Natl. Acad. Sci. U.S.A. 93(8), 3636-3641. (Pubitemid 26127592)
30. Xu, X., Sakon, M., Nagano, H., Hiraoka, N., Yamamoto, H., Hayashi, N., Dono, K., Nakamori, S., Umeshita, K., Ito, Y., Matsuura, N., and Monden, M. (2004) Akt2 expression correlates with prognosis of human hepatocellular carcinoma. Oncol. Rep. 11(1), 25-32.
31. Staal, S. P. (1987) Molecular cloning of the Akt oncogene and its human homologues AKT1 and AKT2: Amplification of AKT1 in a primary human gastric adenocarcinoma. Proc. Natl. Acad. Sci. U.S.A. 84(14), 5034-5037. (Pubitemid 17095859)
32. Heiser, L. M., Sadanandam, A., Kuo, W. L., Benz, S. C., Goldstein, T. C., Ng, S., Gibb, W. J., Wang, N. J., Ziyad, S., Tong, F., Bayani, N., Hu, Z., Billig, J. I., Dueregger, A., Lewis, S., Jakkula, L., Korkola, J. E., Durinck, S., Pepin, F., Guan, Y., Purdom, E., Neuvial, P., Bengtsson, H., Wood, K. W., Smith, P. G., Vassilev, L. T., Hennessy, B. T., Greshock, J., Bachman, K. E., Hardwicke, M. A., Park, J. W., Marton, L. J., Wolf, D. M., Collisson, E. A., Neve, R. M., Mills, G. B., Speed, T. P., Feiler, H. S., Wooster, R. F., Haussler, D., Stuart, J. M., Gray, J. W., and Spellman, P. T. (2012) Subtype and pathway specific responses to anticancer compounds in breast cancer. Proc. Natl. Acad. Sci. U.S.A. 109(8), 2724-2729.